16.95
price down icon7.48%   -1.37
 
loading
Precedente Chiudi:
$18.32
Aprire:
$16.32
Volume 24 ore:
4.51M
Relative Volume:
3.56
Capitalizzazione di mercato:
$2.90B
Reddito:
-
Utile/perdita netta:
$-382.71M
Rapporto P/E:
-6.4695
EPS:
-2.62
Flusso di cassa netto:
$-325.64M
1 W Prestazione:
-5.36%
1M Prestazione:
+7.62%
6M Prestazione:
-26.46%
1 anno Prestazione:
-39.03%
Intervallo 1D:
Value
$15.31
$17.31
Intervallo di 1 settimana:
Value
$15.31
$18.64
Portata 52W:
Value
$12.72
$34.47

Immunovant Inc Stock (IMVT) Company Profile

Name
Nome
Immunovant Inc
Name
Telefono
917-580-3099
Name
Indirizzo
320 WEST 37TH STREET, NEW YORK, NY
Name
Dipendente
362
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
IMVT's Discussions on Twitter

Confronta IMVT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IMVT
Immunovant Inc
16.95 3.13B 0 -382.71M -325.64M -2.62
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Immunovant Inc Stock (IMVT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Ripresa Goldman Neutral
2025-03-03 Iniziato Jefferies Hold
2025-01-03 Downgrade Wolfe Research Outperform → Peer Perform
2024-10-10 Ripresa Raymond James Outperform
2024-10-09 Reiterato Oppenheimer Outperform
2024-03-28 Iniziato Oppenheimer Outperform
2024-03-13 Iniziato Goldman Buy
2024-02-20 Iniziato JP Morgan Overweight
2024-02-15 Iniziato Wolfe Research Outperform
2023-12-12 Iniziato Deutsche Bank Buy
2023-10-13 Aggiornamento UBS Neutral → Buy
2023-09-26 Aggiornamento Raymond James Mkt Perform → Outperform
2023-05-01 Iniziato BofA Securities Buy
2023-04-25 Iniziato Citigroup Buy
2023-03-31 Iniziato Piper Sandler Overweight
2023-03-30 Iniziato Stifel Buy
2023-02-15 Iniziato Cantor Fitzgerald Overweight
2023-02-13 Aggiornamento Guggenheim Neutral → Buy
2023-01-03 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-09-26 Downgrade UBS Buy → Neutral
2021-12-08 Iniziato Wells Fargo Equal Weight
2021-08-03 Downgrade Robert W. Baird Outperform → Neutral
2021-08-02 Downgrade Credit Suisse Neutral → Underperform
2021-06-01 Downgrade Guggenheim Buy → Neutral
2021-06-01 Downgrade Stifel Buy → Hold
2020-10-28 Iniziato UBS Buy
2020-10-12 Iniziato Guggenheim Buy
2020-10-08 Iniziato Stifel Buy
2020-10-02 Iniziato Credit Suisse Outperform
2020-08-26 Reiterato H.C. Wainwright Buy
2020-08-25 Iniziato Raymond James Outperform
2020-07-29 Iniziato H.C. Wainwright Buy
2020-02-24 Iniziato SVB Leerink Outperform
Mostra tutto

Immunovant Inc Borsa (IMVT) Ultime notizie

pulisher
03:17 AM

Bank of New York Mellon Corp Reduces Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

03:17 AM
pulisher
Jul 25, 2025

Immunovant Executives Sell Shares to Cover Tax Obligations - TradingView

Jul 25, 2025
pulisher
Jul 25, 2025

Can Immunovant Inc. stock recover from recent declineHigh-profit stock alerts - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Is Immunovant Inc. a good long term investmentExceptional gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Immunovant Inc. stock priceHigh-profit stock alerts - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Immunovant Inc. stockTremendous wealth creation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Why Immunovant Inc. stock attracts strong analyst attentionFree Daily Stock Market Updates - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Immunovant Inc. stock price go in 2025Free Smart Trading Workshop - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Purchased by Arizona State Retirement System - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Immunovant Inc. Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 19, 2025

Teacher Retirement System of Texas Buys 2,919 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

why immunovant inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For Immunovant (IMVT) - Nasdaq

Jul 17, 2025
pulisher
Jul 16, 2025

(IMVT) Trading Advice - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 16, 2025

All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

Goldman Sachs Resumes Coverage of Immunovant (IMVT) with a Hold Rating - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High? - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Immunovant Inc. stock price move sharplyShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Immunovant Inc. stock performs during market volatilityFree Trading Strategy Suggestions - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Sells 31,255 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

The Goldman Sachs Group Upgrades Immunovant (NASDAQ:IMVT) to Hold - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Immunovant (IMVT) chief technology officer Stout sells $26k in stock - Investing.com Australia

Jul 11, 2025
pulisher
Jul 10, 2025

Goldman Sachs resumes Immunovant stock coverage with Neutral rating By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 07, 2025

Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jul 07, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Jul 07, 2025
pulisher
Jul 06, 2025

(IMVT) Technical Data - news.stocktradersdaily.com

Jul 06, 2025
pulisher
Jun 25, 2025

How to Take Advantage of moves in (IMVT) - news.stocktradersdaily.com

Jun 25, 2025

Immunovant Inc Azioni (IMVT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):